Sissetulev kiriAvalik
Inquiry
Ravimiamet · 3. jaanuar 2024
- Viit
- RST-1/26-1
- Registreeritud
- 3. jaanuar 2024
- Dokumendi liik
- Sissetulev kiri
- Adressaat
- Adivo Associates
- Saabumis/saatmisviis
- e-post
- Funktsioon
- RST Ravimistatistika tegemine
- Sari
- RST-1 Ravimistatistika alane kirjavahetus
- Toimik
- RST-1/2024
- Vastutaja
- Janne Sepp (RA, Ravimiohutuse osakond, Statistikabüroo)
- Lahendamise tähtaeg
- 19. jaanuar 2024
Failid
Sisu (failidest)
Saatja: "Frederik Keulers" <[email protected]>
Saaja: "Ravimiamet" <[email protected]>
Teema: [POSSIBLE SPAM]FOI Request: Human Albumin in Estonia
Kuupäev: 2023-12-20 13:14
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu
saatja korral palume linke ja faile mitte avada.
Hi Ravimiamet team,
I am Frederik Keulers, working at Adivo Associates, an international
consulting agency. Currently, I am working on a project about Human Albumin
use in northern European countries.
I visited the Agency of Medicines website and found a list of Human Albumin
products (ATC: B05AA01). However, I need help finding volumes, patients, or
price information for 2023. Do you know where I could find such information?
It would be helpful if you could let me know if you have any resources.
I wish you a wonderful Christmas time.
Best regards
Frederik Keulers
--
Frederik Keulers
Associate Consultant
ADIVO ASSOCIATES
Mobile: +49 (0) 1735242497
<https://mailfoogae.appspot.com/t?sender=aZnJlZGVyaWsua2V1bGVyc0BhZGl2b2Fzc29jaWF0ZXMuY29t&type=zerocontent&guid=12ef0ef5-215d-4141-b225-863ef601911e>
ᐧ